{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T15:21:39Z","timestamp":1781536899124,"version":"3.54.5"},"reference-count":101,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary & Pancreatic Diseases International"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.hbpd.2021.12.004","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T02:08:21Z","timestamp":1639620501000},"page":"134-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review"],"prefix":"10.1016","volume":"21","author":[{"given":"Zi-Wen","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Quan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Jing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2021.12.004_bib0001","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1200\/JCO.20.02672","article-title":"Systemic therapy for advanced hepatocellular carcinoma: ASCO guideline","volume":"38","author":"Gordan","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0002","first-page":"169","article-title":"New evidence and perspectives on the management of hepatocellular carcinoma with portal vein tumor thrombus","volume":"5","author":"Yin","year":"2017","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0003","doi-asserted-by":"crossref","first-page":"5752","DOI":"10.1007\/s00330-019-06157-0","article-title":"Lipiodol deposition in portal vein tumour thrombus predicts treatment outcome in HCC patients after transarterial chemoembolisation","volume":"29","author":"Yang","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0004","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13578-019-0285-z","article-title":"Short-term and long-term outcomes of liver resection for HCC patients with portal vein tumor thrombus","volume":"9","author":"Huo","year":"2019","journal-title":"Cell Biosci"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0005","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3748\/wjg.v23.i5.906","article-title":"Percutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: a feasibility study","volume":"23","author":"Tarantino","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0006","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jhep.2012.06.014","article-title":"Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial","volume":"57","author":"Bruix","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0007","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0008","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/jcp.27324","article-title":"Comprehensive treatments for hepatocellular carcinoma with portal vein tumor thrombosis","volume":"234","author":"Wang","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0009","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.4254\/wjh.v7.i11.1553","article-title":"Effective treatment strategies other than sorafenib for the patients with advanced hepatocellular carcinoma invading portal vein","volume":"7","author":"Yu","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0010","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0011","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000513486","article-title":"Atezolizumab plus bevacizumab versus sorafenib in the Chinese subpopulation with unresectable hepatocellular carcinoma: phase 3 randomized, open-label IMbrave150 study","volume":"10","author":"Qin","year":"2021","journal-title":"Liver Cancer"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0012","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.3748\/wjg.v25.i31.4360","article-title":"Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers","volume":"25","author":"Cerrito","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0013","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1055-3207(02)00082-0","article-title":"Results of hepatic resection for hepatocellular carcinoma invading major portal and\/or hepatic veins","volume":"12","author":"Ikai","year":"2003","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0014","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s00534-010-0314-0","article-title":"A new classification for hepatocellular carcinoma with portal vein tumor thrombus","volume":"18","author":"Shi","year":"2011","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0015","doi-asserted-by":"crossref","first-page":"696","DOI":"10.5009\/gnl.2013.7.6.696","article-title":"Practical effect of sorafenib monotherapy on advanced hepatocellular carcinoma and portal vein tumor thrombosis","volume":"7","author":"Jeong","year":"2013","journal-title":"Gut Liver"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0016","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis","volume":"64","author":"Wilhelm","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0017","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1055\/s-0038-1666805","article-title":"Hepatocellular carcinoma with portal vein tumor involvement: best management strategies","volume":"38","author":"Liu","year":"2018","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0018","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.ejca.2011.12.006","article-title":"Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: subset analyses of the phase III sorafenib Asia-pacific trial","volume":"48","author":"Cheng","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0019","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3350\/cmh.2016.0071","article-title":"A comparative study of sorafenib and metronomic chemotherapy for Barcelona Clinic Liver Cancer-stage C hepatocellular carcinoma with poor liver function","volume":"23","author":"Yang","year":"2017","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0020","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/jgh.15010","article-title":"Systematic review of hepatic arterial infusion chemotherapy versus sorafenib in patients with hepatocellular carcinoma with portal vein tumor thrombosis","volume":"35","author":"Liu","year":"2020","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0021","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1471-230X-14-84","article-title":"Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis","volume":"14","author":"Nakazawa","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0022","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0023","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000503685","article-title":"Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus (2018 Edition)","volume":"9","author":"Cheng","year":"2020","journal-title":"Liver Cancer"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0024","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.canlet.2012.10.024","article-title":"Sorafenib potentiates irradiation effect in hepatocellular carcinoma in vitro and in vivo","volume":"329","author":"Yu","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3892\/etm.2011.398","article-title":"Cryotherapy is associated with improved clinical outcomes of sorafenib for the treatment of advanced hepatocellular carcinoma","volume":"3","author":"Yang","year":"2012","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0026","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.21873\/anticanres.11211","article-title":"Sorafenib combined with radio-frequency ablation compared with sorafenib alone in treatment of hepatocellular carcinoma invading portal vein: a Western randomized controlled trial","volume":"36","author":"Giorgio","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0027","doi-asserted-by":"crossref","first-page":"7289","DOI":"10.3748\/wjg.v22.i32.7289","article-title":"Management of hepatocellular carcinoma with portal vein tumor thrombosis: review and update at 2016","volume":"22","author":"Chan","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0028","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-230X-13-60","article-title":"Transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a meta-analysis","volume":"13","author":"Xue","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0029","doi-asserted-by":"crossref","first-page":"79816","DOI":"10.18632\/oncotarget.19767","article-title":"The degree of hepatic arterial blood supply of portal vein tumor thrombus in patients with hepatocellular carcinoma and its impact on overall survival after transarterial chemoembolization","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0030","doi-asserted-by":"crossref","first-page":"430","DOI":"10.5001\/omj.2014.114","article-title":"Transarterial chemoembolization in unresectable hepatocellular carcinoma with portal vein thrombosis: a perspective on survival","volume":"29","author":"Ajit","year":"2014","journal-title":"Oman Med J"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0031","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/liv.13719","article-title":"Chemoembolization related to good survival for selected patients with hepatocellular carcinoma invading segmental portal vein","volume":"38","author":"Kim","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0032","doi-asserted-by":"crossref","first-page":"665","DOI":"10.7150\/jca.28528","article-title":"Transarterial chemoembolization related to good survival for selected patients with advanced hepatocellular carcinoma","volume":"10","author":"Le","year":"2019","journal-title":"J Cancer"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0033","first-page":"4231","article-title":"Efficacy of transarterial chemoembolization targeting portal vein tumor thrombus in patients with hepatocellular carcinoma","volume":"34","author":"Tawada","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0034","article-title":"Transarterial chemoembolization for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis: prognostic factors in a single-center study of 188 patients","volume":"2014","author":"Liu","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0035","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1186\/s12885-017-3895-z","article-title":"Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis","volume":"17","author":"Zhang","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0036","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1007\/s00268-013-1969-x","article-title":"Surgical resection versus conformal radiotherapy combined with TACE for resectable hepatocellular carcinoma with portal vein tumor thrombus: a comparative study","volume":"37","author":"Tang","year":"2013","journal-title":"World J Surg"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0037","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1245\/s10434-010-1321-8","article-title":"Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study","volume":"18","author":"Luo","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0038","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.ejso.2019.03.042","article-title":"Transarterial chemoembolization versus best supportive care for patients with hepatocellular carcinoma with portal vein tumor thrombus: a multicenter study","volume":"45","author":"Xiang","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0039","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1016\/j.crad.2014.01.015","article-title":"Transcatheter arterial chemoembolization combined with radiofrequency ablation can improve survival of patients with hepatocellular carcinoma with portal vein tumour thrombosis: extending the indication for ablation?","volume":"69","author":"Zheng","year":"2014","journal-title":"Clin Radiol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0040","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1148\/radiol.14131946","article-title":"Hepatocellular carcinoma with portal vein tumor thrombus: treatment with transarterial chemoembolization combined with sorafenib\u2013a retrospective controlled study","volume":"272","author":"Zhu","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0041","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3748\/wjg.v24.i4.484","article-title":"Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenib","volume":"24","author":"Meng","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0042","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2016.01.012","article-title":"Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: the SPACE trial","volume":"64","author":"Lencioni","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0043","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jhep.2018.11.029","article-title":"Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: the phase III STAH trial","volume":"70","author":"Park","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0044","doi-asserted-by":"crossref","first-page":"6851","DOI":"10.3748\/wjg.v22.i30.6851","article-title":"Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosis","volume":"22","author":"Yu","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0045","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1002\/cncr.21043","article-title":"Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma","volume":"103","author":"Kim","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0046","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/jjco\/hys082","article-title":"Effectiveness of high-dose three-dimensional conformal radiotherapy in hepatocellular carcinoma with portal vein thrombosis","volume":"42","author":"Rim","year":"2012","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0047","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1002\/cam4.1708","article-title":"Comparison of three-dimensional conformal radiotherapy and hepatic resection in hepatocellular carcinoma with portal vein tumor thrombus","volume":"7","author":"Su","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0048","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nrclinonc.2009.188","article-title":"Stereotactic body radiation therapy: a novel treatment modality","volume":"7","author":"Lo","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0049","doi-asserted-by":"crossref","first-page":"e63864","DOI":"10.1371\/journal.pone.0063864","article-title":"Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and\/or inferior vena cava tumor thrombosis","volume":"8","author":"Xi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0050","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/lt.23439","article-title":"Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation","volume":"18","author":"O'Connor","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0051","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/cncr.21237","article-title":"Proton beam therapy for hepatocellular carcinoma with portal vein tumor thrombus","volume":"104","author":"Hata","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0052","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1007\/s00066-009-2020-x","article-title":"Proton-beam therapy for hepatocellular carcinoma associated with portal vein tumor thrombosis","volume":"185","author":"Sugahara","year":"2009","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0053","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.18632\/oncotarget.6118","article-title":"Tolerability and efficacy of gamma knife radiosurgery on hepatocellular carcinoma with portal vein tumor thrombosis","volume":"7","author":"Lu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0054","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/jjco\/hyv205","article-title":"High dose radiotherapy with image-guided hypo-IMRT for hepatocellular carcinoma with portal vein and\/or inferior vena cava tumor thrombi is more feasible and efficacious than conventional 3D-CRT","volume":"46","author":"Hou","year":"2016","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0055","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/hepr.12657","article-title":"Efficacy of the treatment of transarterial chemoembolization combined with radiotherapy for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score analysis","volume":"46","author":"Li","year":"2016","journal-title":"Hepatol Res"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0056","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.3390\/cancers12051116","article-title":"Chemoembolization plus radiotherapy versus chemoembolization plus sorafenib for the treatment of hepatocellular carcinoma invading the portal vein: a propensity score matching analysis","volume":"12","author":"Chu","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0057","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jamaoncol.2017.5847","article-title":"Efficacy and safety of transarterial chemoembolization plus external beam radiotherapy vs sorafenib in hepatocellular carcinoma with macroscopic vascular invasion: a randomized clinical trial","volume":"4","author":"Yoon","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0058","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/hepr.12392","article-title":"Role of 3-D conformal radiotherapy for major portal vein tumor thrombosis combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma","volume":"45","author":"Fujino","year":"2015","journal-title":"Hepatol Res"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0059","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/gutjnl-2015-310292","article-title":"Safety and efficacy of TACE and gamma knife on hepatocellular carcinoma with portal vein invasion","volume":"65","author":"Lu","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0060","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3748\/wjg.v22.i1.407","article-title":"Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: a comprehensive review","volume":"22","author":"Han","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0061","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/hep.26014","article-title":"Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 study","volume":"57","author":"Mazzaferro","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0062","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jhep.2017.12.026","article-title":"Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion","volume":"68","author":"Spreafico","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0063","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00259-015-3210-7","article-title":"Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis","volume":"43","author":"Edeline","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0064","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3348\/kjr.2018.0496","article-title":"Comparison of radioembolization and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis of safety and efficacy","volume":"20","author":"Kim","year":"2019","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0065","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S1470-2045(17)30683-6","article-title":"Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial","volume":"18","author":"Vilgrain","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0066","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.suronc.2015.06.008","article-title":"Is radioembolization ((90)Y) better than doxorubicin drug eluting beads (DEBDOX) for hepatocellular carcinoma with portal vein thrombosis? A retrospective analysis","volume":"24","author":"Akinwande","year":"2015","journal-title":"Surg Oncol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0067","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jhep.2016.05.044","article-title":"Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion","volume":"65","author":"Kokudo","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0068","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1007\/s11605-009-0854-2","article-title":"Surgical strategy for hepatocellular carcinoma patients with portal vein tumor thrombus based on prognostic factors","volume":"13","author":"Kondo","year":"2009","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0069","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s11605-009-0998-0","article-title":"Efficacy of a hepatectomy and a tumor thrombectomy for hepatocellular carcinoma with tumor thrombus extending to the main portal vein","volume":"13","author":"Ban","year":"2009","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0070","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1007\/s00268-013-2296-y","article-title":"The ALPPS procedure: a surgical option for hepatocellular carcinoma with major vascular invasion","volume":"38","author":"Vennarecci","year":"2014","journal-title":"World J Surg"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0071","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.3748\/wjg.v24.i40.4527","article-title":"Better surgical treatment method for hepatocellular carcinoma with portal vein tumor thrombus","volume":"24","author":"Peng","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0072","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/s00595-017-1507-9","article-title":"New macroscopic classification and back-flow thrombectomy for advanced hepatocellular carcinoma with portal vein tumor thrombus invading the contralateral second portal branch","volume":"47","author":"Fukumoto","year":"2017","journal-title":"Surg Today"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0073","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.ejso.2019.03.043","article-title":"A nomogram to predict early postoperative recurrence of hepatocellular carcinoma with portal vein tumour thrombus after R0 liver resection: a large-scale, multicenter study","volume":"45","author":"Zhang","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0074","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1002\/hep.30490","article-title":"An eastern hepatobiliary surgery hospital\/portal vein tumor thrombus scoring system as an aid to decision making on hepatectomy for hepatocellular carcinoma patients with portal vein tumor thrombus: a multicenter study","volume":"69","author":"Zhang","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0075","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.21873\/anticanres.12808","article-title":"Treatment of na\u00efve HCC combined with segmental or subsegmental portal vein tumor thrombosis: liver resection versus TACE followed by radiotherapy","volume":"38","author":"Yu","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0076","doi-asserted-by":"crossref","first-page":"e3015","DOI":"10.1097\/MD.0000000000003015","article-title":"Multimodality treatment for hepatocellular carcinoma with portal vein tumor thrombus: a large-scale, multicenter, propensity mathching score analysis","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0077","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.radonc.2019.05.006","article-title":"Postoperative adjuvant IMRT for patients with HCC and portal vein tumor thrombus: an open-label randomized controlled trial","volume":"140","author":"Sun","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0078","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1200\/JCO.18.02184","article-title":"Neoadjuvant three-dimensional conformal radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a randomized, open-label, multicenter controlled study","volume":"37","author":"Wei","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0079","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3748\/wjg.v21.i1.246","article-title":"Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis","volume":"21","author":"Yamamoto","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0080","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.2147\/OTT.S104307","article-title":"The efficacy and safety of postoperative adjuvant transarterial embolization and radiotherapy in hepatocellular carcinoma patients with portal vein tumor thrombus","volume":"9","author":"Bai","year":"2016","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0081","doi-asserted-by":"crossref","first-page":"6933","DOI":"10.1002\/cam4.2556","article-title":"Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score-matched survival analysis","volume":"8","author":"Gao","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0082","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.3748\/wjg.v22.i15.4034","article-title":"Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma","volume":"22","author":"Li","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0083","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cncr.10246","article-title":"Combined intraarterial 5-fluorouracil and subcutaneous interferon-alpha therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches","volume":"94","author":"Sakon","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0084","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1002\/cncr.21832","article-title":"Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion","volume":"106","author":"Obi","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0085","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.clinthera.2019.04.036","article-title":"Apatinib combined with transarterial chemoembolization in patients with hepatocellular carcinoma and portal vein tumor thrombus: a multicenter retrospective study","volume":"41","author":"Fan","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0086","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/etm.2012.736","article-title":"Combined IFN-\u03b1 and 5-FU treatment as a postoperative adjuvant following surgery for hepatocellular carcinoma with portal venous tumor thrombus","volume":"5","author":"Nagano","year":"2013","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0087","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00280-013-2222-x","article-title":"A multi-institutional phase II trial of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis","volume":"72","author":"Ikeda","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0088","doi-asserted-by":"crossref","first-page":"284","DOI":"10.5009\/gnl19367","article-title":"Comparison of sorafenib versus hepatic arterial infusion chemotherapy-based treatment for advanced hepatocellular carcinoma with portal vein tumor thrombosis","volume":"15","author":"Ahn","year":"2021","journal-title":"Gut Liver"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0089","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1245\/s10434-018-6653-9","article-title":"Downstaging with localized concurrent chemoradiotherapy can identify optimal surgical candidates in hepatocellular carcinoma with portal vein tumor thrombus","volume":"25","author":"Chong","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0090","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s00535-009-0033-y","article-title":"Intra-arterial 5-fluorouracil\/interferon combination therapy for advanced hepatocellular carcinoma with or without three-dimensional conformal radiotherapy for portal vein tumor thrombosis","volume":"44","author":"Katamura","year":"2009","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0091","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00432-008-0513-0","article-title":"Treatment of portal vein tumor thrombus of hepatocellular carcinoma with percutaneous laser ablation","volume":"135","author":"Lu","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0092","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/jso.23306","article-title":"Portal stenting for hepatocellular carcinoma extending into the portal vein in cirrhotic patients","volume":"107","author":"Vibert","year":"2013","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0093","article-title":"Portal vein stenting combined with 125I particle chain implantation followed by As2O3 in the treatment of hepatocellular carcinoma with portal vein tumour thrombus","volume":"2020","author":"Li","year":"2020","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0094","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190279","article-title":"Safety and efficacy of endovascular implantation of a portal vein stent combined with iodine-125 seed-strips followed by transcatheter arterial chemoembolization with sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis","volume":"93","author":"Li","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0095","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1089\/acm.2019.0334","article-title":"Fufang Banmao capsule, a traditional Chinese medicinal formulation, enhances the survival of patients with hepatocellular carcinoma and Vp3-4 portal vein tumor thrombosis undergoing supportive treatment","volume":"26","author":"Liu","year":"2020","journal-title":"J Altern Complement Med"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0096","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1136\/gutjnl-2018-315983","article-title":"Effect of Huaier granule on recurrence after curative resection of HCC: a multicentre, randomised clinical trial","volume":"67","author":"Chen","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0097","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","article-title":"Radiomics: extracting more information from medical images using advanced feature analysis","volume":"48","author":"Lambin","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0098","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jhep.2019.02.023","article-title":"Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma","volume":"70","author":"Xu","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0099","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000494099","article-title":"A radiomics nomogram for preoperative prediction of microvascular invasion in hepatocellular carcinoma","volume":"8","author":"Yang","year":"2019","journal-title":"Liver Cancer"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0100","doi-asserted-by":"crossref","first-page":"9544","DOI":"10.18632\/aging.102403","article-title":"Tree-based classification system incorporating the HVTT-PVTT score for personalized management of hepatocellular carcinoma patients with macroscopic vascular invasion","volume":"11","author":"Cao","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.hbpd.2021.12.004_bib0101","article-title":"Nomogram for individualized prediction of hepatocellular carcinoma with portal vein tumor thrombosis on conservative treatment","volume":"2020","author":"Liu","year":"2020","journal-title":"Biomed Res Int"}],"container-title":["Hepatobiliary & Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387221002290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387221002290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:43:22Z","timestamp":1761493402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387221002290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":101,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1499387221002290"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2021.12.004","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2021.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}